Gregory A. Masters

15.8k citations
127 papers · 6.9k indexed · 5 hit papers · h-index 36

Impact in

  • Oncology top 0.5%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Research Studies 47
    • Cancer Treatment and Pharmacology 16
    • Cancer Immunotherapy and Biomarkers 12
    • Peptidase Inhibition and Analysis 8
    • Lung Cancer Treatments and Mutations 79
    • Lung Cancer Diagnosis and Treatment 45

Gregory A. Masters

125 papers receiving 6.8k citations

Hit Papers

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer 2019 · 352 citations
3522009202620142020250500750

Peers

Gregory A. Masters
Comparison fields: 5 of 130
  • Oncology 4.1k
  • Pulmonary and Respiratory Medicine 4.0k
  • Cancer Research 841
  • Otorhinolaryngology 194
  • Immunology 849
Replace Thomas E. Stinchcombe with:
Thomas E. Stinchcombe United States
Hendrik Dienemann Germany
Élisabeth Quoix France
Kaoru Kubota Japan
Anne S. Tsao United States
Philip Bonomi United States
Anne‐Marie C. Dingemans Netherlands
Petr Zatloukal Czechia
Ashley E. Winkler United States
Johan Vansteenkiste Belgium
Gregory A. Masters relative to Thomas E. Stinchcombe United States Thomas E. Stinchcombe's profile →
Citations per field
00.5×1.5×2.2×
Thomas E. Stinchcombe · 1×
Citations per year

Countries citing papers authored by Gregory A. Masters

Since Specialization
Citations

This map shows the geographic impact of Gregory A. Masters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Masters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Masters more than expected).

Fields of papers citing papers by Gregory A. Masters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory A. Masters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Masters. The network helps show where Gregory A. Masters may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gregory A. Masters, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory A. Masters Line = papers co-authored together Gregory A. Masters links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20231
2 202228
3 20220
4 20223
5 20191
6 2017139
7
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Hit paper breakdown →
2017471
8 20150
9
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
Hit paper breakdown →
2009752
10 200925
11 200814
12 20082
13 200541
14 20045
15 20031
16 2003159
17 200218
18 200234
19 200216
20 1998129

About Gregory A. Masters

Gregory A. Masters is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Cancer Research and Radiation, having authored 127 papers that have together received 6.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (79 papers), Lung Cancer Research Studies (47 papers), Lung Cancer Diagnosis and Treatment (45 papers), Cancer therapeutics and mechanisms (19 papers), Cancer Treatment and Pharmacology (16 papers), Neuroendocrine Tumor Research Advances (15 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Peptidase Inhibition and Analysis (8 papers). The work is most often cited by research in Oncology (4.1k citations), Pulmonary and Respiratory Medicine (4.0k citations), Cancer Research (841 citations), Otorhinolaryngology (194 citations) and Immunology (849 citations). Gregory A. Masters has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Sarah Temin, Joan H. Schiller, Sherman Baker, Thomas J. Smith, Julie R. Brahmer, Giuseppe Giaccone, David H. Johnson, Everett E. Vokes, John R. Strawn and Christopher G. Azzoli. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Journal of Thoracic Oncology, Annals of Oncology and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026